Originally published April 16, 2008 at 12:00 AM | Page modified June 30, 2008 at 2:10 PM
Corrected version
Pathway Medical raises $24.5 million for plaque device
Pathway Medical Technologies said Tuesday that it has raised $24.5 million in venture capital from existing investors — money geared...
Seattle Times business reporter
Pathway Medical Technologies said Tuesday that it has raised $24.5 million in venture capital from existing investors — money geared to help the firm launch its first commercial product later this year.
The latest cash influx brings the total raised by the Kirkland-based medical-device maker to about $80 million, Chief Executive Tom Clement said. The company's newly padded war chest should last it until revenue starts coming in from sales of its system for clearing out arterial plaque.
"We shouldn't need another round of investment in the next year and a half, if that," Clement said.
Pathway seeks to market a device to treat peripheral-arterial disease by sending a catheter with rotating blades up an artery to bore through accumulated fat and vacuum the debris away.
The device, under review by the U.S. Food and Drug Administration, is to be used in patients' legs to improve circulation and prevent amputations. It could be an alternative to surgery and other methods, which include widening blood vessels and costly laser catheters that burn plaque away.
Pathway's main rival is Fox Hollow, of Redwood City, Calif., which sells the SilverHawk, a catheter to remove plaque from peripheral arteries.
Boston Scientific markets a similar product, called the Rotablator, for the treatment of coronary arterial disease. That device was developed by Redmond-based Heart Technology, which the Massachusetts company later acquired.
The fresh infusion of cash is the latest act in Pathway's revival. The company briefly shut down in late 2004 when it ran out of money. But Clement, a Heart Technology veteran who helped develop the Rotablator, persuaded investors to give the company a new start.
Confident that the market will embrace Pathway's product, the venture backers behind the previous financings — HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and other individual investors — didn't want anybody else admitted to the latest funding round, Clement said.
"They asked that we did the round internally," he said.
Pathway has some 100 employees. After receiving FDA approval, expected in the third quarter, the company intends to expand as it creates a sales and marketing team, but Clement declined to say how many jobs would be created.
Local medical-device companies have been enjoying venture capital's favor lately. Last month, Redmond-based Spiration raised $18.5 million from existing investors to fund the launch of a catheter-like technology to treat severe emphysema.
Ángel González: 206-515-5644 or agonzalez@seattletimes.com
Material from The Seattle Times archives is included in this story.
Information in this article, originally published April 16, 2008, was corrected June 30, 2008. A previous version of this story incorrectly stated that Pathway Medical Technologies' chief executive is Tom Clements. His name was misspelled.
Copyright © 2008 The Seattle Times Company
Chase shrugs off loss of CD investors
Sunday Buzz: Expedia, Intelius, Classmates slapped by Senate report
Denny Triangle gains skyline, but tenants slow to come
UPDATE - 04:28 PM
Senate Democrats at odds over health care bill
Your Funds: Money for nothing: Some investors pay for advice they never get

LA Galaxy's David Beckham
Los Angeles Galaxy's David Beckham talks about the upcoming MLS Cup final during after a team practice.
nwjobs

Post a comment

Michelle Goodman blogs about work/life balance.
How to tell your office you're gravely ill
Post a comment
nwautos

Choosing a new sedan? Weigh the impact of your choice on your wallet and on the planet.
Post a comment
- 'The Road' takes Viggo Mortensen to Mount St. Helen's and Astoria, Ore.
- Craigslist adoption ad: A plea by young mother-to-be? A scam?
- Italian lead prosecutor argues Knox motive was hatred
- Italian prosecutors request life sentence for UW student
- Child-support error costs nearly $21,000
- Man shot in chest on E. Union Street in Capitol Hill
- Tugboat sinks in Seattle's waterfront
- Washington state wines make annual best-of list
- Mariners Blog | A Mariners-Tigers swap makes a whole lot of sense for both teams
- Lynnwood is reinventing itself — again
- Senate vote clears hurdle
234 - Mariners add six to 40-man roster
149 - Tight Senate vote launches health care over hurdle
119 - Child-support error costs nearly $21,000
116 - Palin excitement builds in Tri-Cities
110 - Vikings easily beat the Seahawks
107 - Cutting through breast-cancer confusion
86 - Prosecutor requests life in prison for Amanda Knox
86 - Game thread
69 - New York terror trials will restore faith in rule of law
51
- Washington state wines make annual best-of list
- Nonprofits get creative using Twitter and Facebook to make donation easier
- It's possible to recover a life lost to hoarding
- Lynnwood is reinventing itself — again
- Great places to cross-country ski for free (or almost) in the Methow
- Child-support error costs nearly $21,000
- 'The Road' takes Viggo Mortensen to Mount St. Helen's and Astoria, Ore.
- Recipes: Sesame Pork Roast, Sour Cream Mashed Potatoes, Gingerbread with Lemon Sauce and more
- Banff: powder, peaks & purity
- 175 foster kids in Washington get 'forever families'





